New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome June 29, 2026
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome June 29, 2026
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome June 29, 2026
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome June 29, 2026
GPK DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Graphic Packaging Holding Company Investors with Losses in Excess of $100K to Secure Counsel Before Important July 6 Deadline in Securities Class Action – GPK June 29, 2026
